Abstract
The nature of anesthetic practice is such that a rapid and complete reversal of drug effect is often needed. The introduction of new pharmacological agents with favorable and rapid recovery curves is welcome because it allows us to change the level of effect very quickly and insures a faster disappearance of effect and fewer unwanted residual effects like partial paralysis, undue sedation or respiratory depression. Nevertheless, because longer acting agents are still used in many cases, antagonistic compounds are still needed. The present review will cover the antagonism of muscle relaxants, benzodiazepines, narcotics, and a very peculiar form of antagonism of anesthetic effects seen after the administration of physostigmine (Antilirium®).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Savarese JJ, Miller RD, Lien CA, Caldwell JE: Pharmacology of muscle relaxants and their antagonists. Anesthesia. Edited by Miller RD. New York, Churchill Livingstone, 1994, pp 417–87
Bevan DR, Donati F, Kopman AF: Reversal of neuromuscular blockade. Anesthesiology 77:785–805, 1992
Beemer GH, Bjorksten AR, Dawson PJ: Determinants of the reversal time of competitive neuromuscular blockade by anticholinesterase drugs. Br J Anesth 66:469, 1991
Donati F, Lahoud J, McCready D, Bevan DR: Neostigmine, pyridostigmine and edrophonium as antagonists of moderate and profound atracurium blockade. Can J Anaesth 34:589–93, 1987
Rupp SM, McChristen J, Miller RD: Neostigmine and edrophonium antagonism of varying intensity of neuromuscular blockade by atracurium, pancuronium or vecuronium. Anesthesiology 64:711, 1986
Delisle S, Bevan DR: Impaired neostigmine antagonism of pancuronium during enflurane anesthesia in man. Br J Anaesth 54:441, 1982
Baurain MJ, D’Hollander AA, Melot C: Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 74:474, 1991
Ali HH, Wilson RS, Savarese JJ, Kitz RJ: The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth 47:570–4, 1975
Brand JB, Cullen DJ, Wilson NE, Ali HH: Spontaneous recovery from nondepolarizing neuromuscular blockade: Correlation between clinical and evoked responses. Anesth Analg 56:55–8, 1977
Thomas PD, Worthlet LIG, Russell WJ: How useful is visual and tactile assessment of neuromuscular blockade using a peripheral nerve stimulator? Anaesth Intensive Care 12:6869, 1984
Dupuis JY, Martin R, Tessonnier JM, Tetrault JP: Clinical assessment of the muscular response to tetanic nerve stimulation. Can J Anaesth 37:397–400, 1990
Partridge BL, Ward CF: Pulmonary edema following low-dose naloxone administration. Anesthesiology 65:709–10, 1986
Bailey PL, Clark NJ, Pace NL, et al: Failure of nalbuphine to antagonize morphine. Anesth Analg 65:605, 1986
Mendelson WB: Neuropharmacology of sleep induction by benzodiazepines. Neurobiology 16:221, 1992
Fiset P, Lemmens HLM, Egan TE, Shafer SL, Stanski DR: Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharmacol Ther 58:567–82, 1995
Hill GE, Stanley TH, Sentker CR: Physostigmine reversal of postoperative somnolence. Can J Anaesth 24:707–11, 1977
Toro-Matos A, Rendon-Platas AM, Avila-Valdez E, Villarreal-Guzman RA: Physostigmine antagonizes ketamine. Anesth Analg 59:764–7, 1980
Caldwell CB, Gross JB: Physostigmine reversal of midazolam-induced sedation. Anesthesiology 57:125–7, 1982
Smith DB, Clark RB, Stephens SR, Sherman RL, Hyde ML: Physostigmine reversal of sedation in parturients. Anesth Analg 55:478–80, 1976
Artru AA, Hui GS: Physostigmine reversal of general anesthesia for intraoperative neurological testing: associated EEG changes. Anesth Analg 65:1059–62, 1986
Snir-Mor I, Weinstock M, Davidson JT, Bahar M: Physostigmine antagonizes morphine-induced respiratory depression in human subjects. Anesthesiology 59:6–9, 1983
Fassoulaki A, Sarantopoulos C, Derveniotis C: Physostigmine increases the dose of propofol required to induce anaesthesia. Can J Anaesth 44:1148–51, 1997
Meuret P, Backman S, Bonhomme V, Plourde G, Fiset P: Effect of physostigmine on propofol-induced loss of consciousness and changes in evoked auditory responses in man. Society for Neuroscience 1997(Abstract)
Bonhomme V, Meuret P, Backman SB, Plourde G, Fiset P: Cholinergic mechanisms mediating propofol-induced loss of consciousness. Can J Anaesth 45:A52–B1998 (Abstract)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fiset, P. (1999). Antagonism of Anesthetic Effects. In: Stanley, T.H., Egan, T.D. (eds) Anesthesia for the New Millennium. Developments in Critical Care Medicine and Anesthesiology, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4566-4_28
Download citation
DOI: https://doi.org/10.1007/978-94-011-4566-4_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5935-0
Online ISBN: 978-94-011-4566-4
eBook Packages: Springer Book Archive